Mrs Lorraine P Side, MA MS RN CS APRN in Perkiomenville, PA - Medicare Counselor

Mrs Lorraine P Side, MA MS RN CS APRN is a medicare enrolled "Counselor - Addiction (substance Use Disorder)" in Perkiomenville, Pennsylvania. Her current practice location is 2151 Deep Creek Rd, Perkiomenville, Pennsylvania. You can reach out to her office (for appointments etc.) via phone at (215) 541-9089.

Mrs Lorraine P Side is licensed to practice in * (Not Available) (license number ) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1811084098.

Contact Information

	Mrs Lorraine P Side, MA MS RN CS APRN
	2151 Deep Creek Rd, Perkiomenville, PA 18074
	(215) 541-9089
	(215) 679-3144

Provider's Profile

Full Name	Mrs Lorraine P Side
Gender	Female
Speciality	Counselor - Addiction (substance Use Disorder)
Location	2151 Deep Creek Rd, Perkiomenville, Pennsylvania
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1811084098
Provider Enumeration Date: 10/06/2006
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 8426057407
Enrollment ID: I20061221000034

Medical Identifiers

Medical identifiers for Mrs Lorraine P Side such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1811084098	NPI	-	NPPES
0005815320	Other		AETNA
0492730000	Other		KEYSTONE & AMERIHEALTH

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
364S00000X	Clinical Nurse Specialist	RN248822L (Pennsylvania)	Primary
101YP2500X	Counselor - Professional	(* (Not Available))	Primary
101YA0400X	Counselor - Addiction (substance Use Disorder)	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Lorraine P Side is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Lorraine P Side, MA MS RN CS APRN 2151 Deep Creek Rd, Perkiomenville, PA 18074 Ph: (215) 541-9089	Mrs Lorraine P Side, MA MS RN CS APRN 2151 Deep Creek Rd, Perkiomenville, PA 18074 Ph: (215) 541-9089

News Archive

Article analyzes role of nutrition in mood swings

In this study, preliminary data yields conflicting but mainly positive evidence for the use of n-3 fatty acids and chromium in the treatment of bipolar depression. Limited evidence found that inositol may be helpful for bipolar depression, but larger sample sizes are needed. Preliminary randomized, controlled trials suggest that choline, magnesium, folate and tryptophan may be beneficial for reducing symptoms of mania.

Elimination of HIV transmission by 2030 might be within reach among MSM in England

The annual number of new HIV infections among men who have sex with men (MSM) in England is likely to have fallen dramatically, from 2,770 in 2013 to 854 in 2018, showing elimination of HIV transmission by 2030 to be within reach - suggests work by researchers from the MRC Biostatistics Unit at the University of Cambridge and Public Health England (PHE), published in The Lancet HIV.

Osiris receives consent from NZ to market Prochymal for GvHD

Osiris Therapeutics, Inc., announced today it has received consent from New Zealand to market its first-in-class stem cell therapy Prochymal (remestemcel-L), for the treatment of acute graft-vs-host disease (GvHD) in children.

Inverness Medical Innovations to participate in J. P. Morgan Healthcare Conference

Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the J.P. Morgan Healthcare Conference being held January 11 through 14, 2010 at the Westin St. Francis Hotel in San Francisco.

Study demonstrates feasibility to detect generalized tonic-clonic seizures with arm device

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures, or convulsions, during activities of daily living. Two new studies presented at the American Epilepsy Society's 67th Annual Meeting in Washington D.C. provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.

Mrs Lorraine P Side, MA MS RN CS APRN - Medicare Counselor in Perkiomenville, PA